Wnt signaling in cardiac remodeling and heart failure

25Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Wnt signaling plays an essential role during development, but is also activated in diseases as diverse as neurodegeneration, osteoporosis, and cancer. Accumulating evidence demonstrates that Wnt signaling is also activated during cardiac remodeling and heart failure. In this chapter, we will provide a brief overview of Wnt signaling in all its complexity. Then we will discuss the evidence for its involvement in the development of cardiac hypertrophy, the wound healing after myocardial infarction (MI) and heart failure. Finally, we will provide an overview of the drugs that are available to target Wnt signaling at different levels of the signaling cascade and the results of these pharmacological interventions in cardiac disease.

Cite

CITATION STYLE

APA

Stylianidis, V., Hermans, K. C. M., & Blankesteijn, W. M. (2017). Wnt signaling in cardiac remodeling and heart failure. In Handbook of Experimental Pharmacology (Vol. 243, pp. 371–393). Springer New York LLC. https://doi.org/10.1007/164_2016_56

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free